a Configuration Analyst with excellent problem-solving skills, to help new and existing clients optimize the use of Benevity...: ● 2+ years of experience in either of the following roles: Technical Solutions Analyst/Technical Business Analyst...
PURPOSE Supports the testing activities and quality validation of products that satisfy customer needs by applying software testing principles, standards and knowledge KEY RESPONSIBILITIES AND ACCOUNTABILITIES 1) Gathers testing requi...
a Configuration Analyst with excellent problem-solving skills, to help new and existing clients optimize the use of Benevity...: ● 2+ years of experience in either of the following roles: Technical Solutions Analyst/Technical Business Analyst...
Company Description IFS is a billion-dollar revenue company with 6000+ employees on all continents. Our leading AI technology is the backbone of our award-winning enterprise software solutions, enabling our customers to be their best when...
The new top team includes the UK's first female chancellor, Rachel Reeves, as well as party veterans such as Ed Miliband and Yvette Cooper. Continue Reading »
Spot gold was up 1.1% at $2,380.91 per ounce as of 11:08 a.m. Bullion is up more than 2% for the week so far. U.S. gold futures gained 0.8% to $2,389.10. Continue Reading »
Top dividend yield stocks: Coal India and Gujarat State Fertilisers & Chemicals are on Religare Broking's list of top 10 dividend yield stocks. Continue Reading »
Budget 2024: Hemal Shah of Torus ORO PMS has suggested L&T, HDFC Bank, Canfin Homes, and Oil India ahead of the upcoming Union Budget saying that the stocks can benefit most out of the policy announcements. Continue Reading »
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »